1. BiondVax Pharmaceuticals Ltd.

    0 Comments Leave a Comment

    1-1 of 1
    1. Mentioned In 1 Articles

    2. New Directors Elected to BiondVax's Board of Directors

      New Directors Elected to BiondVax's Board of Directors
      JERUSALEM,March 24, 2020/PRNewswire/ --BiondVax Pharmaceuticals Ltd.(Nasdaq: BVXV), developer of the universal influenza vaccine candidate M-001, announced that all proposed resolutions were approved at the Company's Annual General Meeting held today, including the election of three new directors to the Company's Board of Directors, namely, Dr.Yael Margolin, Mr.Adi Raviv, and Mr. Samuel Moed...
      Read Full Article
    3. 1-1 of 1
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content